IP Archives of Cytology and Histopathology Research
Official Publication of Khyati Education and Research Foundation
Official Publication of Khyati Education and Research Foundation
Print ISSN: 2581-5725
Online ISSN: 2456-9267
CODEN : IACHCL
IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...Short Communication
Author Details :
Volume : 5, Issue : 3, Year : 2020
Article Page : 262-265
https://doi.org/10.18231/j.achr.2020.058
Abstract
The measurement of quality matrix has become increasingly important in current health care environment. Quality management system have been recommended by accreditation bodies to reduce errors in surgical pathology but there is strong need of standardization so that errors are kept to minimal thereby improved patient care. The histopathology report influences patient treatment decisions and therefore a good histopathology report should be reliable, timely, addressing to clinician demand. Any error has lethal consequences for patients. The paper gives a lucid review of quality control in histopathology.
Keywords: Histopathology, Quality control, Laboratory.
How to cite : Sareen R, Govil A, Gupta G N, To prevent error is sign of triumph: Quality control in surgical pathology. IP Arch Cytol Histopathol Res 2020;5(3):262-265
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
